A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/196 (2006.01) A61K 31/44 (2006.01) A61P 1/06 (2006.01) A61P 13/06 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2650853
The present invention is directed to the prevention, reversal and medical treatment of dystonia and dyskinesia as well as other diseases related to movement disorders, both in human beings and animals by administering a neuronal potassium channel opener such as flupirtine, retigabine or maxipost.
La présente invention a pour but la prévention, l'inversion et le traitement médical de la dystonie et de la dyskinésie ainsi que d'autres maladies liées aux troubles moteurs, tant chez les humains que chez les animaux, par administration d'un ouvreur de canaux potassiques neuronal tel que la flupirtine, la rétigabine ou le maxipost.
Richter Angelika
Rundfeldt Chris
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Rundfeldt Chris
LandOfFree
Potassium channel activators for the prevention and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Potassium channel activators for the prevention and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potassium channel activators for the prevention and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1562096